CLINICAL_TRIALS
withdrawal
· 2024-01-31
Clinical Trial Update: The Avastin vs Visudyne for Neovascular AMD Study [Phase 3]
Summary
A Phase 3 trial comparing Avastin to Visudyne for neovascular age-related macular degeneration was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: St. Erik Eye Hospital | Conditions: Age-related Macular Degeneration | Phase 3 | Status: WITHDRAWN